Status:

UNKNOWN

Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease

Lead Sponsor:

Swedish Institute for Infectious Disease Control

Conditions:

Diphtheria

Tetanus

Eligibility:

All Genders

Brief Summary

This is a randomized cross-sectional study of the Swedish population. Blood samples will be collected from a subpopulation in order to estimate the age specific sero-prevalence of the Swedish populati...

Detailed Description

Besides the main objectives stated in the summary, the study consists of: Vaccine related objectives: * To estimate the seroprevalence regarding vaccine preventable diseases in the cohort of childre...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • informed written consent (both groups)
  • immigrated to Sweden after 6 years of age from a country with polio vaccination coverage \< 85 % (Sub study group)
  • living and attending school in Stockholm, Gothenburg or Malmoe (Sub study group)

Exclusion

    Key Trial Info

    Start Date :

    March 1 2007

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    September 1 2011

    Estimated Enrollment :

    5400 Patients enrolled

    Trial Details

    Trial ID

    NCT00932269

    Start Date

    March 1 2007

    End Date

    September 1 2011

    Last Update

    July 3 2009

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Swedish Institute for Infectious Disease Control

    Solna, Sweden, 171 82